MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

A

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Search

AmerisourceBergen Corporation

Fechado

SetorSaúde

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Indicadores-chave

By Trading Economics

Rendimento

-1B

-340M

Vendas

3.1B

84B

P/E

Médio do Setor

44.635

89.037

EPS

3.84

Rendimento de Dividendos

0.62

Margem de lucro

-0.406

Funcionários

47,000

EBITDA

-1.1B

183M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+15.51% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.62%

2.18%

Próximos Ganhos

4 de fev. de 2026

Próxima data de dividendos

2 de mar. de 2026

Próxima data de ex-dividendo

13 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2.7B

69B

Abertura anterior

0

Fecho anterior

0

Sentimento de Notícias

By Acuity

58%

42%

286 / 352 Ranking em Healthcare

AmerisourceBergen Corporation Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de jan. de 2026, 18:41 UTC

Ganhos

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

24 de jan. de 2026, 09:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

24 de jan. de 2026, 09:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

24 de jan. de 2026, 09:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

24 de jan. de 2026, 09:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

24 de jan. de 2026, 06:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 de jan. de 2026, 22:30 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de jan. de 2026, 22:30 UTC

Conversa de Mercado

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 de jan. de 2026, 22:03 UTC

Ganhos

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 de jan. de 2026, 21:52 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

23 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

23 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

23 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

23 de jan. de 2026, 21:39 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 de jan. de 2026, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 de jan. de 2026, 21:12 UTC

Ganhos

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 de jan. de 2026, 20:31 UTC

Ganhos

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 de jan. de 2026, 20:12 UTC

Conversa de Mercado

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 de jan. de 2026, 20:07 UTC

Conversa de Mercado

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 de jan. de 2026, 19:36 UTC

Conversa de Mercado

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 de jan. de 2026, 19:30 UTC

Conversa de Mercado
Ganhos

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 de jan. de 2026, 19:18 UTC

Conversa de Mercado

Gold and Silver Step Up to More Records -- Market Talk

23 de jan. de 2026, 19:15 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

23 de jan. de 2026, 18:53 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

23 de jan. de 2026, 18:21 UTC

Ganhos

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

23 de jan. de 2026, 18:19 UTC

Conversa de Mercado

Intel Seen as Increasingly Confident on Demand -- Market Talk

23 de jan. de 2026, 17:59 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

23 de jan. de 2026, 17:57 UTC

Conversa de Mercado

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

23 de jan. de 2026, 17:57 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

Comparação entre Pares

Variação de preço

AmerisourceBergen Corporation Previsão

Preço-alvo

By TipRanks

15.51% parte superior

Previsão para 12 meses

Média 408.3 USD  15.51%

Máximo 440 USD

Mínimo 371 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para AmerisourceBergen Corporation - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

11 ratings

10

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

286 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat